Vinay Prasad is returning to his role at the U.S. Food and Drug Administration, a little more than a week after he had left the agency as director of the Center for Biologics Evaluation and Research.

WASHINGTON — Vinay Prasad is returning to the Food and Drug Administration to resume his role overseeing vaccine, gene therapy, and blood product regulation. “At the FDA’s request, Dr. Vinay Prasad is resuming leadership of the Center for Biologics Evaluation and Research,” Health and Human Services spokesperson Andrew Nixon told STAT on Saturday.

DIRECTING A CHANGING CDC — The Senate voted to confirm Susan Monarez as the next CDC director Tuesday, marking an end to the agency’s four-month stint without a director or acting head and setting her up to helm an agency that’s undergoing a rapid transformation.

Vinay Prasad is returning to his role at the U.S. Food and Drug Administration to resume overseeing vaccine, gene therapy and blood product regulation, STAT News reported on Saturday.